Incyte Corp. sell BMO Capital Markets
Start price
30.07.25
/
50%
€67.88
Target price
30.07.26
€51.87
Performance (%)
22.51%
Price
15:37
€83.16
Summary
This prediction is currently active. The prediction currently has a disappointing performance of 22.51%. This prediction currently runs until 30.07.26. The prediction end date can be changed by BMO_Capital_Markets at any time. BMO_Capital_Markets has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Incyte Corp. | 0.929% | 0.929% |
| iShares Core DAX® | 0.060% | 1.215% |
| iShares Nasdaq 100 | -3.065% | -0.519% |
| iShares Nikkei 225® | -2.094% | -3.066% |
| iShares S&P 500 | -1.657% | -0.069% |
Comments by BMO_Capital_Markets for this prediction
In the thread Incyte Corp. diskutieren
Incyte Corporation (NASDAQ: INCY) had its price target raised by analysts at BMO Capital Markets from $52.00 to $60.00. They now have an "underperform" rating on the stock.
Ratings data for INCY provided by MarketBeat